These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Prevention of experimental diabetes induced by chelating agents]. Lazaris IaA; Bavel'skiĭ ZE Patol Fiziol Eksp Ter; 1968; 12(6):38-42. PubMed ID: 5744106 [No Abstract] [Full Text] [Related]
4. [Some regularities in the distribution of zinc, insulin and acid phosphatase in the islands of Langerhans of rabbits during the development of diabetes produced by selective injury of B cells]. Toroptsev IV; Eshchenko VA Arkh Patol; 1971; 33(3):43-9. PubMed ID: 4945986 [No Abstract] [Full Text] [Related]
5. Diabetogenic activity of chelators in some mammalian species. Goldberg ED; Eshchenko VA; Bovt VD Endocrinologie; 1990; 28(2):51-5. PubMed ID: 2293327 [TBL] [Abstract][Full Text] [Related]
6. [Experimental diabetes caused by 5-(n-acetaminophenylazo-8-oxyquinoline and its prevention]. Lazaris AIa; Bavel'skiĭ ZE Patol Fiziol Eksp Ter; 1970; 14(2):44-8. PubMed ID: 5474018 [No Abstract] [Full Text] [Related]
8. [Role of chelate-forming compounds in disorders of the incretory function of the pancreas]. Lazaris IaA; Veksler RI Vopr Med Khim; 1967; 13(3):256-60. PubMed ID: 4876365 [No Abstract] [Full Text] [Related]
15. Antimalarial activity of selected aromatic chelators. II. Substituted quinolines and quinoline-N-oxides. Scheibel LW; Adler A Mol Pharmacol; 1981 Jul; 20(1):218-23. PubMed ID: 6793844 [No Abstract] [Full Text] [Related]
16. Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [ 4 , 3 -a ] quinoline derivatives as potent anticonvulsants. Guan LP; Jin QH; Tian GR; Chai KY; Quan ZS J Pharm Pharm Sci; 2007; 10(3):254-62. PubMed ID: 17727789 [TBL] [Abstract][Full Text] [Related]
17. [Attempts at induction of a diabetic condition in guinea pigs by different 8-hydroxy-quinolines]. Fiedler H Pharmazie; 1969 Jun; 24(6):338-40. PubMed ID: 5807397 [No Abstract] [Full Text] [Related]